These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29426768)

  • 21. Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues.
    Lee DY; Karnati VV; He M; Liu-Chen LY; Kondaveti L; Ma Z; Wang Y; Chen Y; Beguin C; Carlezon WA; Cohen B
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3744-7. PubMed ID: 15993589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.
    Riley AP; Groer CE; Young D; Ewald AW; Kivell BM; Prisinzano TE
    J Med Chem; 2014 Dec; 57(24):10464-75. PubMed ID: 25426797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and B.
    Bikbulatov RV; Yan F; Roth BL; Zjawiony JK
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2229-32. PubMed ID: 17303418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents.
    Walentiny DM; Vann RE; Warner JA; King LS; Seltzman HH; Navarro HA; Twine CE; Thomas BF; Gilliam AF; Gilmour BP; Carroll FI; Wiley JL
    Psychopharmacology (Berl); 2010 Jun; 210(2):275-84. PubMed ID: 20354680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.
    Wang Y; Tang K; Inan S; Siebert D; Holzgrabe U; Lee DY; Huang P; Li JG; Cowan A; Liu-Chen LY
    J Pharmacol Exp Ther; 2005 Jan; 312(1):220-30. PubMed ID: 15383632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
    Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.
    Cruz A; Domingos S; Gallardo E; Martinho A
    Phytochemistry; 2017 May; 137():9-14. PubMed ID: 28190678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy.
    Béguin C; Potter DN; Dinieri JA; Munro TA; Richards MR; Paine TA; Berry L; Zhao Z; Roth BL; Xu W; Liu-Chen LY; Carlezon WA; Cohen BM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):188-95. PubMed ID: 17951511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Kappa Opioid Receptor and the Sleep of Reason: Cortico-Subcortical Imbalance Following Salvinorin-A.
    Ona G; Sampedro F; Romero S; Valle M; Camacho V; Migliorelli C; Mañanas MÁ; Antonijoan RM; Puntes M; Coimbra J; Ballester MR; Garrido M; Riba J
    Int J Neuropsychopharmacol; 2022 Jan; 25(1):54-63. PubMed ID: 34537829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CoMFA analyses of C-2 position salvinorin A analogs at the kappa-opioid receptor provides insights into epimer selectivity.
    McGovern DL; Mosier PD; Roth BL; Westkaemper RB
    J Mol Graph Model; 2010 Apr; 28(7):612-25. PubMed ID: 20083418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human kappa opioid receptors.
    Lee DY; Ma Z; Liu-Chen LY; Wang Y; Chen Y; Carlezon WA; Cohen B
    Bioorg Med Chem; 2005 Oct; 13(19):5635-9. PubMed ID: 16084728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioisosteric modification of salvinorin A, a potent and selective kappa-opioid receptor agonist.
    Stewart DJ; Fahmy H; Roth BL; Yan F; Zjawiony JK
    Arzneimittelforschung; 2006; 56(4):269-75. PubMed ID: 16724512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total synthesis of the hallucinogenic neoclerodane diterpenoid salvinorin A.
    Nozawa M; Suka Y; Hoshi T; Suzuki T; Hagiwara H
    Org Lett; 2008 Apr; 10(7):1365-8. PubMed ID: 18311991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and in vitro pharmacological studies of C(4) modified salvinorin A analogues.
    Lee DY; He M; Kondaveti L; Liu-Chen LY; Ma Z; Wang Y; Chen Y; Li JG; Beguin C; Carlezon WA; Cohen B
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4169-73. PubMed ID: 16051487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors.
    Capasso R; Borrelli F; Cascio MG; Aviello G; Huben K; Zjawiony JK; Marini P; Romano B; Di Marzo V; Capasso F; Izzo AA
    Br J Pharmacol; 2008 Nov; 155(5):681-9. PubMed ID: 18622408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of 2-alkyl-2-methoxymethyl-salvinorin ethers as selective κ-opioid receptor agonists.
    Lee DY; Deng G; Ma Z; Xu W; Yang L; Liu J; Dai R; Liu-Chen LY
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4689-92. PubMed ID: 26330078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvinorin A reduces neuropathic nociception in the insular cortex of the rat.
    Coffeen U; Canseco-Alba A; Simón-Arceo K; Almanza A; Mercado F; León-Olea M; Pellicer F
    Eur J Pain; 2018 Feb; 22(2):311-318. PubMed ID: 28975684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of C-12 triazole and oxadiazole analogs of salvinorin A.
    Yang L; Xu W; Chen F; Liu-Chen LY; Ma Z; Lee DY
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1301-4. PubMed ID: 19211245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of neoclerodane diterpenes and their pharmacological effects.
    Lovell KM; Prevatt-Smith KM; Lozama A; Prisinzano TE
    Top Curr Chem; 2011; 299():141-85. PubMed ID: 21630517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects.
    Butelman ER; Rus S; Prisinzano TE; Kreek MJ
    Psychopharmacology (Berl); 2010 Jun; 210(2):253-62. PubMed ID: 20084367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.